Font Size: a A A
Keyword [heart valve]
Result: 181 - 200 | Page: 10 of 10
181. Clinical Application Of Radiofrequency Ablation Treating Atrial Fibrilation During Heart Valve Replacement
182. Protective Effects Of Levosimendan On The Myocardial Cells In Heart Valve Replacement Surgery
183. To Compare The Early And Middle-long-term Results Of Tricuspid Valve Replacement With Mechanical Or Biological Prostheses
184. Analysis Of Related Factors Of Chronic Left Ventricular Systolic Dysfunction After Heart Valve Replacement
185. Effects Of CYP2C9and VKORC1Genetic Polymorphisms On Response To Stable Warfarin Dose In Patients With Heart Valve Replacement
186. In-hospital Mortality Factor Analysis Early After Heart Valve Surgery
187. The Impact Of Group Visits On Anticoagulant Therapy Of Warfarin Of Patients Undergoing Mechanical Heart Valve Replacement
188. Comparison Of The Effects Of Methyl Prednisolone And Dexamethasone On Lung Function In Patients Undergoing Heart Valve Replacement With Cardiopulmonary Bypass
189. The Clinical Observation Of Tranexamic Acid On Valve Replacement Operation Under Cardiopulmonary Bypass
190. Effects Of Blood Cardioplegia With Exogenous Creatine Phosphate On CTnI And Life Quality In Patients With Heart Valve Replacement
191. Risk Factors Of Recurrence Of Valvular Atrial Fibrillation After Surgical Radiofrequency Ablation
192. Influence Of Genetic Polymorphisms On Warfarin Stable Dose In Han Chinese Patients With Mechanical Heart Valve Replacement
193. Surgical Experience Of Severe Heart Valve Disease
194. The Research And Design Of Artificial Heart Valve Heart Sound Monitoring System Based On FPGA
195. Effects Of Remifentanil And Fentanyl On The CTnI And H-FABP In Patients Undergoing Heart Valve Replacement
196. Portective Effects Of Ulinastatin On Liver And Kidney For Patients Of Perioperative Period In Cardiopulmonary Bypass During Cardiac Valve Replacement
197. The Clinical Observation Of The Recovery Of Lung Function After Using Ulinastatin During Cardiopulmonary Bypass After Heart Valve Replacement
198. The Changes Of Perioperative Serum CTn-I By Using Esmolol Toarrest The Heart Valves Replacement
199. Reseach On Myocardial Protection Of Recombinant Human Erythropoietin Pretreatment In Rheumatic Heart Valve Disease Perioperation
200. The Modified De Vega Suture Annuloplasty Prevent Mild Functional Tricuspid Regurgitation From Progressing
  <<First  <Prev  Next>  Last>>  Jump to